---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-084687"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2026-08-03T20:47:55+00:00"
generated_at: "2026-08-03T20:49:09.171259+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics 2026 annual meeting voting results; all proposals approved

## Summary
- Elected Judith Shizuru and Tom Wiggans as Class II directors with ~9.27M and ~9.28M votes for, respectively.
- Ratified PricewaterhouseCoopers as independent auditor for FY2026 with 20.6M votes for (97.7% of votes cast).
- Advisory say-on-pay approved with 9.0M for, 604k against, 73k abstain (excluding 11.4M broker non-votes).
- Quorum of 75% (21.1M of 28.0M shares) represented at the July 31, 2026 meeting.

## SEC filing metadata
- accession: 0001213900-26-084687
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2026-08-03T20:47:55+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390026084687/0001213900-26-084687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026084687/ea0300286-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-084687
- JSON: https://secwatch.observer/filing/0001213900-26-084687.json
- Plain text: https://secwatch.observer/filing/0001213900-26-084687.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.